# Intranasal Insulin and Olanzapine Study in Healthy Volunteers

> **NCT03741478** · PHASE1 · UNKNOWN · sponsor: **Centre for Addiction and Mental Health** · enrollment: 64 (estimated)

## Conditions studied

- Healthy Controls

## Interventions

- **DRUG:** OLANZapine 2.5 MG
- **DRUG:** Placebo
- **DRUG:** Insulin Lispro 100 UNT/ML
- **OTHER:** Saline

## Key facts

- **NCT ID:** NCT03741478
- **Lead sponsor:** Centre for Addiction and Mental Health
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-10-22
- **Primary completion:** 2024-07-30
- **Final completion:** 2024-07-30
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2023-07-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03741478

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03741478, "Intranasal Insulin and Olanzapine Study in Healthy Volunteers". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT03741478. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*